Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • elizzybethy
    Junior Member
    • Sep 2009
    • 8

    #1

    Can DEXSeq output variance stabilized data like DESeq?

    I am interested in how exposure to a certain drug affects gene expression levels and splicing in cell lines. We have cell lines derived from over 100 different (human) individuals and have exposed each to control buffer and drug in vitro, so pairing our RNA-seq data when making any differential expression/splicing comparisons is vital. (There is so much variability in expression levels between cell lines that it swamps the drug-induced expression changes, even if every cell line changes in the same direction, if the data are not paired for the comparison.)

    I found that outputting variance stabilized data from DESeq and then conducting a simple paired t-test was much more powerful than any other differential gene expression approach I have tried thus far for this dataset (including using cell line identity as a covariate in the generalized linear model.) I would like to try a similar approach using exon-level data to investigate splicing, and was wondering if there is a way to export variance-stabilized exon-level data from DEXSeq, and if so, how? (I am a relative R novice, so example code would be much appreciated.)

    If there isn't a way to do this in DEXSeq, and one isn't in the pipeline for being implemented soon, I am wondering if there are any other suggestions for conducting differential splicing/exon analysis without sacrificing the inherent power in our paired dataset?

Latest Articles

Collapse

  • SEQadmin2
    Beyond CRISPR/Cas9: Understand, Choose, and Use the Right Genome Editing Tool
    by SEQadmin2



    CRISPR/Cas9 sparked the gene editing revolution for both research and therapeutics.1 But this system still showed severe issues that limited its applications. The most prominent were the heavy reliance on PAM sequences, delivery limitations, double-stranded breaks that prompt unintended edits and cell death, and editing inefficiency (both in targeting and in knock-in reliability).

    Despite this, “CRISPR helped turn genome editing from a specialized technique into
    ...
    07-31-2026, 11:01 AM
  • SEQadmin2
    Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
    by SEQadmin2


    Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

    The systematic characterization of the human proteome has
    ...
    07-20-2026, 11:48 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by SEQadmin2, 08-06-2026, 07:41 AM
0 responses
17 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 08-03-2026, 10:13 AM
0 responses
33 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 07-31-2026, 02:55 AM
0 responses
43 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 07-24-2026, 12:17 PM
0 responses
26 views
0 reactions
Last Post SEQadmin2  
Working...